Search

Your search keyword '"Aittomäki, Kristiina"' showing total 1,059 results

Search Constraints

Start Over You searched for: Author "Aittomäki, Kristiina" Remove constraint Author: "Aittomäki, Kristiina"
1,059 results on '"Aittomäki, Kristiina"'

Search Results

1. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

2. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank

3. High-Resolution Genotyping of Formalin-Fixed Tissue Accurately Estimates Polygenic Risk Scores in Human Diseases

4. NTHL1 is a recessive cancer susceptibility gene

5. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

6. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

7. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

8. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

9. The public health impact of poor sleep on severe COVID-19, influenza and upper respiratory infections

10. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

11. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

12. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

13. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

14. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

15. Risk of Midlife Stroke After Adverse Pregnancy Outcomes: The FinnGen Study

16. Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women

17. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

18. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

19. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.

20. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

21. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

22. The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

23. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.

24. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

25. Correction: Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

26. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

27. Association analysis identifies 65 new breast cancer risk loci

28. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

29. Genetic modifiers of CHEK2*1100delC-associated breast cancer risk

30. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.

31. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

32. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

33. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

34. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

35. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

36. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

37. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

38. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

39. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

40. RAD51B in Familial Breast Cancer.

42. Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

43. A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients

44. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

45. Prediction of breast cancer risk based on profiling with common genetic variants.

46. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

47. Identification of six new susceptibility loci for invasive epithelial ovarian cancer.

48. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.

49. Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1

50. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.

Catalog

Books, media, physical & digital resources